Janus Henderson Group’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History
Bought
Maintained
Sold
Other funds holding NBP
HA
SL
ACM
CS
WP
EAM
Janus Henderson Group's NBP Position: Q1 2026 in Review
Janus Henderson Group reduced its NovaBridge Biosciences American Depositary Shares (NBP) stake by 28% in Q1 2026, selling an estimated $8.05M and leaving 6,032,650 shares worth $14.8M. The position accounts for 0.01% of the portfolio, ranked #664.
Janus Henderson Group first reported a position in NBP in Q3 2025 and has held it in 3 quarters since. The position peaked at $33.6M in Q4 2025. 48 funds tracked by Wall St. Rank hold NBP as of Q1 2026.
- Janus Henderson Group held 6,032,650 shares of NovaBridge Biosciences American Depositary Shares worth $14.8M as of Q1 2026.
- Janus Henderson Group sold 2,403,991 NovaBridge Biosciences American Depositary Shares shares in Q1 2026, an estimated $8.05M.
- NovaBridge Biosciences American Depositary Shares made up 0.01% of Janus Henderson Group's portfolio in Q1 2026, its #664 holding.
- Janus Henderson Group first reported a position in NovaBridge Biosciences American Depositary Shares in Q3 2025 and has held it in 3 quarters since.
- Janus Henderson Group's NovaBridge Biosciences American Depositary Shares position peaked at $33.6M in Q4 2025.
- 48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2026.
Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.